-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – YA-101 in Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - YA-101 in Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. YA-101 in Multiple System...
-
Product Insights
NewInfluenza A Virus, H3N2 Subtype Infections – Drugs In Development, 2024
Empower your strategies with our Influenza A Virus, H3N2 Subtype Infections – Drugs In Development, 2024 report and make more profitable business decisions. H3N2 infections are caused by variant H3N2 virus, which is a strain of influenza. Symptoms include cough, sore throat, runny or stuffy nose, chills, nausea, vomiting, and/or diarrhea. Risk factors include age and chronic medical conditions like asthma, diabetes, heart disease, weakened immune systems, and neurological or neurodevelopment conditions. Treatment includes antiviral medications and antibiotics. The Influenza A...
-
Product Insights
NewRabies – Drugs In Development, 2024
Empower your strategies with our Rabies – Drugs In Development, 2024 report and make more profitable business decisions. Rabies is a deadly virus spread to people from the saliva of infected animals. The rabies virus is usually transmitted through a bite. Symptoms include loss of feeling in an area of the body, loss of muscle function, difficulty swallowing, excitability, fever, and convulsions. The predisposing factors include exposure to wildlife and exposure to pets that are not vaccinated. The Rabies drugs in...
-
Product Insights
NewInfluenzavirus B Infections – Drugs In Development, 2024
Empower your strategies with our Influenzavirus B Infections – Drugs In Development, 2024 report and make more profitable business decisions. Type B influenza is a subtype of the influenza virus that tends to occur sporadically. Symptoms include runny nose, sore throat, aching muscles, malaise, watery eyes, aching body, loss of appetite, and weakness. Treatment includes antivirals, analgesics, and antipyretics medications. The Influenzavirus B Infections drugs in development market research report provide comprehensive information on the therapeutics under development for Influenzavirus B...
-
Product Insights
NewInfluenza A Virus, H1N1 Subtype Infections – Drugs In Development, 2024
Empower your strategies with our Influenza A Virus, H1N1 Subtype Infections – Drugs In Development, 2024 report and make more profitable business decisions. H1N1 infection, also known as swine flu, is a new kind of flu in humans caused by a contagious influenza virus strain. H1N1 flu infects the nose, throat, and lungs. It is spread by droplets distributed by coughing or sneezing. Signs and symptoms include cough, fever, sore throat, stuffy or runny nose, body aches, headache, and fatigue. Treatment...
-
Product Insights
NewInfluenzavirus A Infections – Drugs In Development, 2024
Empower your strategies with our Influenzavirus A Infections – Drugs In Development, 2024 report and make more profitable business decisions. Influenza A virus infections are caused by a type of influenza virus with a high capacity for genetic variation. It is more serious than the common cold and can cause major outbreaks and severe disease. It spreads through droplets from the nose or throat of an infected person, usually through coughing and sneezing. The proteins on the surface of the influenza...
-
Product Insights
Feixianguan
Feixianguan is a Hydro project located in Sichuan, China. The project is owned by Changjiang River Resource Hydropower Development Corporation; China Huaneng Group Co Ltd; Sichuan Electric Power Development Company; Ya~an Electric Power Co Ltd; Ya~an State-owned Assets Operation Co., Ltd. and was developed by Sichuan Baoxing River Electric Power Co., Ltd.. The project is currently active. Empower your strategies with our Feixianguan report and make more profitable business decisions. Note: This is an on-demand report that will be delivered...
-
Product Insights
Xiaoguanzi
Xiaoguanzi is a Hydro project located in Sichuan, China. The project is owned by China Huaneng Group Co Ltd; Sichuan Electric Power Development Co., Ltd.; Ya~an Electric Power Holdings Limited; Ya~an Hydropower Development Co., Ltd.; Yangtze New Energies Development CO., Ltd. and was developed by Sichuan Baoxing River Electric Power Co., Ltd.. The project came online in 2000. Empower your strategies with our Xiaoguanzi report and make more profitable business decisions. Note: This is an on-demand report that will be...
-
Product Insights
Baoxing
Baoxing is a Hydro project located in Sichuan, China. The project is owned by Changjiang River Resource Hydropower Development Corporation; China Huaneng Group Co Ltd; Sichuan Electric Power Development Co., Ltd.; Ya~an Electric Power Co Ltd; Ya~an State-owned Assets Operation Co., Ltd. and was developed by Sichuan Huaneng Baoxing River Electric Power Co Ltd. The project came online in 2009. Empower your strategies with our Baoxing report and make more profitable business decisions. Note: This is an on-demand report that...
-
Product Insights
Yucheng
Yucheng is a Hydro project located in Sichuan, China. The project is owned by Changjiang River Resource Hydropower Development Corporation; China Huaneng Group Co Ltd; Sichuan Power Development Company; Ya~an Electric Power Co Ltd; Ya~an Hydropower Development Company and was developed by Sichuan Baoxing River Electric Power Co., Ltd.. The project came online in 1995. Empower your strategies with our Yucheng report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request....